Partner with us
Help us build the medication safety layer
African healthcare is missing
We are looking for hospitals, research institutions, distribution partners, and investors who understand what's at stake — and want to be part of fixing it.
Track 1
Hospital Pilot Partner
We are onboarding a small number of founding hospitals in 2026 — facilities that will be the first to deploy KEMIRIX in a real clinical environment. These partners will shape the product, co-author the validation research, and receive preferential pricing when we go to market.
- Early access to KEMIRIX before public launch
- Dedicated implementation and integration support
- Co-authorship of clinical validation research
- Preferential pricing as a founding pilot partner
- Direct input into product roadmap and features
- Joint press release and case study publication
What to expect
Track 2
Research Partnership
We are looking for academic medical centres, schools of public health, and pharmacogenomics research groups to co-develop peer-reviewed studies on AI-assisted clinical outcomes in African populations.
- Access to de-identified clinical data (with ethics approval)
- Joint grant application support — WHO, NIH, Wellcome Trust
- Co-authorship on peer-reviewed publications
- KEMIRIX academic research license
- Access to clinical validation dataset
- Dedicated research engineering support
Research areas we care about
Clinical outcomes of AI-assisted prescribing in low-resource settings
Pharmacogenomics prevalence in African populations
Drug-traditional medicine interactions — African TM knowledge mapping
Offline AI inference accuracy in rural clinical environments
Health equity impact of clinical decision support across income-disparate facilities
Antimicrobial resistance and stewardship in sub-Saharan Africa
Track 3
Distribution Partnership
If you have established relationships with healthcare institutions in your region and the operational capacity to support clinical software deployments, we want to talk.
- Competitive revenue share model
- Full technical and clinical training
- Marketing co-investment for your region
- Regional exclusivity options available
- Dedicated partner success manager
- Priority support SLA
What we look for in a distribution partner
Established relationships with hospital systems or government health ministries
Operating in one or more African or emerging market countries
A team that can support SaaS clinical software implementation
Understanding of the SaMD regulatory landscape in your target market
Genuinely committed to improving clinical outcomes
Track 4
Strategic Investment
KEMIRIX is a first-mover in a category that doesn't yet exist at scale in Africa. We are building the clinical AI infrastructure that will define healthcare in the world's fastest-growing region.
We are pursuing seed investment to accelerate our hospital pilot programme, strengthen our regulatory pathway, and expand our clinical knowledge base. We welcome healthcare-focused VCs, impact investors, and strategic corporate investors.
Investor Inquiry →Why now
Healthcare AI in Africa is almost entirely absent. The clinical decision support tools that hospitals in Europe and the US rely on every day do not exist here — not at scale, not built for this context. KEMIRIX is being built to fill that gap, starting in Kenya.
Get in touch
Submit a Partnership Inquiry
We respond to all partnership enquiries within 48 hours. Or email us directly at admin@kemirix.com